NT-proBNP Levels in Cardiovascular Disease and Its Comparison with Others Biochemical Indicators

郭炫,王利公,李和平,王刚,马利娟,王晓娜
DOI: https://doi.org/10.3969/j.issn.1671-7414.2008.05.007
2008-01-01
Abstract:Objectives To study the levels of NT-pro Brain Natriuretic Peptide(NT-proBNP) in cardiovascular disease and comparison with others biochemical indicators.Methods By Roche Elecsys2010 electrochemiluminescence assay plasma NT-proBNP and cardiac troponinT(cTnT) leves in 376 patients with cardiovascular disease and 61 of normal controls were measured.And cardiac troponinI2(cTnI2),moyglobine(MYO) and creatin kinase myocardial type(CK-MB) were measured.Study the correlations of plasma NT-proBNP concentration with severity of heart failure,underling heart disease and functional classifications(NYHA) in patients with cardiovascular diseas.Results The plasma Log NT-proBNP concentrations of patients were significantly higher than those of the normal controls 3.38±0.36 fmol/ml vs 2.45±0.10 fmol/ml(P0.001).Furthermore the concentrations of NT-proBNP between every 2 subgroups with different type cardiovascular diseases had significant differences(F=23.167,P0.001) and they also increased with the increased severity of heart failure according to NYHA functional classification(P0.001).There were significant differences between every 2 subgroups with different type cardiovascular diseases among the patients with NYHA functional.Conclusion The plasma levels of NT-proBNP increased significantly with the increased severity of heart failure(NYHA functional classes).But there was a significant increase in cTnT,cTnI2,MYO and CK-MB of acute myocardial infarction.At the early stage of cardiac function injury,different cardiovascular diseases may contribute to the increase of plasma NT-proBNP differently.
What problem does this paper attempt to address?